-
Parasitic Disease of the Gastrointestinal Tract: Surgical Aspects. Visc. Med. (IF 1.9) Pub Date : 2023-09-15 Ernst Klar
-
Endoscopic Ultrasound in Pancreatology: Focus on Inflammatory Diseases and Interventions. Visc. Med. (IF 1.9) Pub Date : 2023-09-05 Francesco Vitali,Sebastian Zundler,Daniel Jesper,Deike Strobel,Dane Wildner,Nicoló de Pretis,Luca Frulloni,Stefano Francesco Crinó,Markus F Neurath
Background Endoscopic ultrasound (EUS) is a main tool in pancreatology for both diagnosis and therapy. It allows minimally invasive differentiation of various diseases, with a minimal degree of inflammation or anatomic variations. EUS also enables interventional direct access to the pancreatic parenchyma and the retroperitoneal space, the pancreatic duct, the pancreatic masses, cysts, vascular structures
-
Clinical Value of Clip-and-Snare Assisted Endoscopic Submucosal Resection in Treatment of Rectal Neuroendocrine Tumors. Visc. Med. (IF 1.9) Pub Date : 2023-09-05 Xin-Tong Jiang,Yang Hu,Jian Gong,Shi-Bin Guo
Introduction The aim of the study was to introduce a new endoscopic technology, clip-and-snare assisted endoscopic submucosal resection (CS-ESMR), for treatment of rectal neuroendocrine tumors (NETs) and then to investigate the therapeutic value of CS-ESMR. Methods In this retrospective study, 67 patients who underwent endoscopic treatment of rectal NETs from March 2017 to December 2021 were analyzed
-
Diagnostic Endoscopic Ultrasound in Pancreatology: Focus on Normal Variants and Pancreatic Masses. Visc. Med. (IF 1.9) Pub Date : 2023-09-05 Francesco Vitali,Sebastian Zundler,Daniel Jesper,Dane Wildner,Deike Strobel,Luca Frulloni,Markus F Neurath
Background Endoscopic ultrasound (EUS) is a main tool in gastroenterology for both diagnosis and exclusion of pancreatic pathology. It allows minimally invasive assessment of various diseases or anatomic variations affecting the pancreas also with the help of new Doppler technologies, elastography, contrast-enhanced imaging including post hoc image processing with quantification analyses, three-dimensional
-
Safety and Feasibility of Cholecystectomy with the HugoTM RAS: Proof of Setup Guides and First-In-Human German Experience. Visc. Med. (IF 1.9) Pub Date : 2023-08-09 Orlin Belyaev,Tim Fahlbusch,Illya Slobodkin,Wademar Uhl
Introduction The Hugo RAS robotic platform by Medtronic was recently certified for human use in Europe. Several centers have gained initial experience with this system in urology and gynecology. However, few data about its feasibility and safety in general surgery have been published. Methods The first-in-human surgical procedures with the Hugo RAS in Germany were performed at our hospital in February
-
Removable Transduodenal Bypass: Development of a New Endoscopic Concept. Visc. Med. (IF 1.9) Pub Date : 2023-07-14 Alida Finze,Mirko Otto,Georg Kähler
Introduction Obesity and obesity-related disease such as diabetes mellitus type 2 are a permanently rising concern worldwide. Current effective therapeutic options mostly include medication and surgery, but there is a lack of effective treatment options between medication and surgery. Previously, devices such as EndoBarrier® have been placed on the market. However, high complication rates, especially
-
Biliary Parasitic Diseases Associated with Hepatobiliary Carcinoma. Visc. Med. (IF 1.9) Pub Date : 2023-07-12 Taigo Hata,Ito Hiromichi
Background Despite long-term preventative efforts by local public health authorities, the prevalence of fluke infection remains high in specific areas in eastern and southeastern Asia. Recently increasing travel or migration activities have led to the transfer and spread of such infections from endemic areas to other regions. Summary The epidemiology, clinical signs, and symptoms for three common blood
-
C. perfringens Blood Stream Infection due to Nontransmural Ischemia of the Esophagus, Stomach, and Left Colon: Case Report. Visc. Med. (IF 1.9) Pub Date : 2023-06-12 Johannes Reiner,Katharina Reichenbach,Imad Kamaleddine,Daniel Mokosch,Felix Streckenbach,Beate Brinkmann,Annette Pertschy,Maria Witte,Clemens Schafmayer,Marc-André Weber,Georg Lamprecht
We report the case of a 74-year-old female with abdominal pain, tarry stools, and tachycardia. Previous history included diabetes mellitus with micro- and macroangiopathy. Imaging revealed portal gas, left sided colitis, and emphysematous gastritis, besides severe atherosclerosis with subtotal celiac trunk occlusion and moderate stenosis of the inferior mesenteric artery. Upper endoscopy revealed findings
-
Current and Emerging Targeted Therapies for Ulcerative Colitis. Visc. Med. (IF 1.9) Pub Date : 2023-06-12 Robert Pietschner,Timo Rath,Markus F Neurath,Raja Atreya
Background Ulcerative colitis is one of the main entities of inflammatory bowel diseases. The clinical course of this immune-mediated disorder is marked by unpredictable exacerbations and asymptomatic remission, causing lifelong morbidity. Optimized anti-inflammatory treatment is a prerequisite to not only restore the quality of life of the affected patients but also halt progressive bowel damage and
-
Fluorescent Imaging in Visceral Surgery: Current Opportunities and Future Perspectives. Visc. Med. (IF 1.9) Pub Date : 2023-06-12 Philipp H von Kroge,Anna Duprée
Background Fluorescent imaging using indocyanine green (FI-ICG) has become quite popular in the past century, giving the surgeon various pre- and intraoperative approaches in visceral surgery. Nevertheless, several aspects and pitfalls of using the technology need to be addressed. Summary This article focused on the applications of FI-ICG in esophageal and colorectal surgery as this is where the clinical
-
-
Current Surgical Concepts in Lynch Syndrome and Familial Adenomatous Polyposis Visc. Med. (IF 1.9) Pub Date : 2023-03-28 Karoline Horisberger, Carolina Mann, Hauke Lang
Background: Approximately 5% of colorectal cancers (CRCs) are associated with hereditary cancer syndromes. The natural history of these syndromes differs from sporadic cancers, and due to their increased risk of metachronous carcinomas, surgical approaches also differ. This review focuses on the current recommendations for surgical treatment and what evidence has led to these recommendations in the
-
Endoscopic Vacuum Therapy for Treating an Esophago-Pulmonary Fistula after Esophagectomy: A Case Report and Review of the Literature Visc. Med. (IF 1.9) Pub Date : 2023-02-23 Imad Kamaleddine, Magdalena Popova, Ahmad Alwali, Clemens Schafmayer
An acquired esophago-respiratory fistula represents an abnormal connection between the esophagus and the respiratory system. It is usually caused by malignancy and infection, or it occurs as a complication after surgery or radiation therapy. It can be divided according to its anatomical level into esophago-tracheal fistula, esophago-bronchial fistula, and in the rarest case, esophago-pulmonary fistula
-
Colitis ulcerosa - Upadacitinib als neue orale Therapieoption Visc. Med. (IF 1.9) Pub Date : 2023-02-08
Visc Med
-
-
-
-
-
-
Diagnostic and Therapeutic Management of Early Colorectal Cancer Visc. Med. (IF 1.9) Pub Date : 2022-11-30 Mathilda Knoblauch, Florian Kühn, Viktor von Ehrlich-Treuenstätt, Jens Werner, Bernhard Willibald Renz
Background: Early colorectal cancer (eCRC) is defined as cancer that does not cross the submucosal layer of the colon or rectum, including carcinoma in situ (pTis), pT1a, and pT1b. Early carcinomas differ in their prognosis depending on the risk profile. The differentiation between low and high risk is essential. The low-risk group includes R0-resected, well (G1) or moderately (G2) differentiated tumors
-
Acute Mesenteric Ischemia: Preexisting Comorbidity Determines Short-Term Outcome and Quality of Life in Long-Term Survivors Visc. Med. (IF 1.9) Pub Date : 2022-11-24 Maria Witte, Manuela Neese, Matthias Leuchter, Mark Philipp, Ernst Klar, Clemens Schafmayer
Introduction: Acute mesenteric ischemia (AMI), either arterial or venous, is still a devastating disease with poor prognosis. It is unknown, whether AMI is associated with impaired quality of life (QoL) in long-term survivors. Material and Methods: This retrospective analysis includes 64 patients with occlusive arterial or venous mesenteric ischemia treated operatively between 2008 and 2016 at the
-
-
Clinical Implications of Postoperative Hyperamylasemia after Partial Pancreaticoduodenectomy Visc. Med. (IF 1.9) Pub Date : 2022-10-24 Ioannis Mintziras, Sabine Wächter, Jerena Manoharan, Veit Kanngiesser, Elisabeth Maurer, Detlef K. Bartsch
Introduction: The present study aimed to examine the clinical implications of postoperative hyperamylasemia (POH) after partial pancreaticoduodenectomy (PD). Methods: Data from all consecutive patients undergoing PD were obtained from a prospectively maintained database and reviewed. POH was defined as an elevation of serum pancreatic amylase above the upper limit of normal (53 U/L) on postoperative
-
Postoperative Management in Visceral Medicine Visc. Med. (IF 1.9) Pub Date : 2022-10-21 Florian Kühn, Christian Schulz
Visc Med 2022;38:1–2
-
Endoscopic Accessibility of the Biliary System in the Postoperative Situs Visc. Med. (IF 1.9) Pub Date : 2022-10-21 Benedikt Aulinger, Kerstin Schütte, Christian Schulz
Background: Alterations in the anatomy of the upper gastrointestinal tract may pose a challenge to the endoscopist, especially if interventions to the biliary system are indicated in patients with altered continuity of the gastrointestinal tract, impeding to reach the papilla with conventional ERC techniques. The success of any endoscopic intervention in this setting depends on optimal knowledge on
-
Interventional Radiology Options after Visceral Surgery Visc. Med. (IF 1.9) Pub Date : 2022-10-21 Sinan Deniz, Osman Öcal, Florian Kühn, Martin Kurt Angele, Jens Werner, Florian Streitparth
Background: Postoperative management of patients undergoing visceral surgery can present challenging clinical situations with significant morbidity and mortality. Interventional radiological techniques offer quick, safe, and effective minimally invasive treatment options in the postoperative management of visceral surgery. Summary: Most commonly done procedures include – but are not limited to – fluid
-
The Need of Antimicrobial Stewardship in Post-Operative Infectious Complications of Abdominal Surgery Visc. Med. (IF 1.9) Pub Date : 2022-10-21 Wilfried Obst, Torben Esser, Achim Jens Kaasch, Gernot Geginat, Frank Meyer, Roland S. Croner, Verena Keitel
Background: Post-operative infection is a common complication following abdominal surgery. The two most common infections are secondary peritonitis and surgical site infections, which lead to increased perioperative morbidity, prolonged hospitalization, higher mortality rates, and increased treatment costs. In addition to surgical procedures, treatment is based on effective antibiotic therapy. Due
-
Interdisciplinary Discussion on Postoperative Management in Visceral Medicine Visc. Med. (IF 1.9) Pub Date : 2022-10-21 Florian Kühn, Christian Schulz, Arved Weimann, Patrick Scheiermann, Steffen Seyfried, Christoph Reissfelder
Visc Med 2022;38:1–4
-
Endoscopic Treatment Options for Gastrointestinal Leaks Visc. Med. (IF 1.9) Pub Date : 2022-10-14 Moritz Drefs, Josefine Schardey, Viktor von Ehrlich-Treuenstätt, Ulrich Wirth, Maria Burian, Petra Zimmermann, Jens Werner, Florian Kühn
Background: Spontaneous or postoperative gastrointestinal defects are still life-threatening complications with elevated morbidity and mortality. Recently, endoscopic treatment options – up and foremost endoscopic vacuum therapy (EVT) – have become increasingly popular and have shown promising results in these patients. Methods: We performed an electronic systematic search of the MEDLINE databases
-
Patient-Tailored Approach for Enhanced Recovery after Surgery Visc. Med. (IF 1.9) Pub Date : 2022-10-13 Steffen Seyfried, Florian Herrle, Patrick Téoule, Alexander Betzler, Christoph Reissfelder
Background: Enhanced recovery after surgery (ERAS®) is increasingly finding its way into clinical practice. ERAS® protocols have not been universally adopted, and they have often been criticized for being difficult to implement. So, the question for more tailor-made approaches arises. Methods: We conducted a literature search on March 16, 2022, using the following search string, which was modified
-
Postoperative Nutrition Management: Who Needs What? Visc. Med. (IF 1.9) Pub Date : 2022-10-03 Maria Wobith, Arved Weimann
Background: Early oral feeding after major abdominal surgery has been clearly shown to be safe and not a risk factor for anastomotic dehiscence. Within the Enhanced Recovery after Surgery protocol, it is the nutritional plan A. Nonetheless, one must consider that postoperative protein and energy requirements will often be not covered by oral food intake alone. Because nutritional status has been shown
-
The Clinical Importance of Preoperative Rectal Swabs in Patients after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Visc. Med. (IF 1.9) Pub Date : 2022-08-18 Philippa Seika, Susanne Marz, Christine Geffers, Thomas Adam, Linda Feldbrügge, Maximilian Jara, Johann Pratschke, Beate Rau
Background: Surgical site infections are among the most common healthcare-associated infections, especially in patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). The aim of this retrospective study was to examine postoperative infectious complications according to preoperative screening findings of nasal and rectal swabs. Methods: Two hundred four
-
152-Wochen-Daten zum Erstlinien-Biologikum Ustekinumab bei CU Visc. Med. (IF 1.9) Pub Date : 2022-08-11
Visc Med 2022;38:301–304
-
-
Mirizzi Syndrome: Is There a Place for Minimally Invasive Surgery? Visc. Med. (IF 1.9) Pub Date : 2022-08-10 Aistė Gulla, Marta Jasaitė, Laura Bilotaitė, Kestutis Strupas
Objectives: Mirizzi syndrome (MS) is a condition when an impacted stone in the cystic duct or the Hartmann’s pouch due to its extrinsic compression and concomitant inflammation causes an obstruction of the common bile duct. Laparotomy was the preferred surgical technique to treat this syndrome. However, with advances in technologies, an increasing number of surgeons are starting to choose minimally
-
Usefulness of Liver Uptake Rate Constant in 99mTc-GSA Scintigraphy for the Risk Stratification of Patients Undergoing Hepatectomy: A New Method for Calculation Visc. Med. (IF 1.9) Pub Date : 2022-08-04 Yuzo Yamamoto, Yoshihiro Abukawa, Kimihiko Sato, Go Watanabe, Yasuhiko Nakagawa, Manabu Hashimoto, Masatake Iida
Introduction: The use of technetium 99m diethylenetriaminepentaacetic acid-galactosyl human serum albumin (99mTc-GSA) scintigraphy parameters, HH15 and LHL15, in assessing the future liver remnant function is not expedient because of their nonlinear behaviour against liver volume. Uptake rate constant for the binding of 99mTc-GSA to asialoglycoprotein receptors is probably more favourable, but the
-
-
Today’s Mistakes and Tomorrow’s Wisdom in the Surgical Treatment of Barrett’s Adenocarcinoma Visc. Med. (IF 1.9) Pub Date : 2022-05-24 Giovanni Maria Garbarino, Mark Ivo van Berge Henegouwen, Suzanne Sarah Gisbertz, Wietse Jelle Eshuis
Background: Barrett’s esophagus is a premalignant condition caused by longstanding gastroesophageal reflux disease and may progress to low-grade dysplasia, high-grade dysplasia (HGD), and finally esophageal adenocarcinoma. Summary: Barrett’s adenocarcinoma can be treated either by endoscopic or surgical resection, depending on the clinical staging. Endoscopic resection is a safe and adequate treatment
-
Barrett’s Esophagus: Today’s Mistakes and Tomorrow’s Wisdom Visc. Med. (IF 1.9) Pub Date : 2022-05-18 Roos E. Pouw, Oliver Pech, Rehan Haidry, Raf Bisschops, Timo Rath, Suzanne Gisbertz
Visc Med
-
Barrett’s Esophagus: Today’s Mistakes and Tomorrow’s Wisdom Visc. Med. (IF 1.9) Pub Date : 2022-05-12 Roos E. Pouw, Oliver Pech
Visc Med
-
Computed Tomography Assessment of Gastric Band Slippage Visc. Med. (IF 1.9) Pub Date : 2022-05-06 Jeremy R. Burt, Madison R. Kocher, Lauren Snider, Jeffrey Waltz, Jordan Heston Chamberlin, Gilberto J. Aquino, Vincent Giovagnoli, Megan Mercer, Nicholas Feranec
Background: The purpose of this study was to develop and validate reliable computed tomography (CT) imaging criteria for the diagnosis of gastric band slippage. Material and Methods: We retrospectively evaluated 67 patients for gastric band slippage using CT. Of these, 14 had surgically proven gastric band slippage (study group), 22 had their gastric bands removed for reasons other than slippage (control
-
Today’s Mistakes and Tomorrow’s Wisdom… in the Management of T1b Barrett’s Adenocarcinoma Visc. Med. (IF 1.9) Pub Date : 2022-04-25 Man Wai Chan, Esther A. Nieuwenhuis, Roos E. Pouw
Background: Given the limitation that endoscopic resection only enables local intraluminal treatment without lymphadenectomy, the standard treatment of esophageal adenocarcinoma (EAC) with invasion of the submucosa (T1b) has long been surgical esophageal resection. However, in recent literature, the risk of lymph node metastases (LNM) associated with T1b EAC appears to be lower than previously assumed
-
-
-
Today’s Mistakes and Tomorrow’s Wisdom in Endoscopic Imaging of Barrett’s Esophagus Visc. Med. (IF 1.9) Pub Date : 2022-03-30 Lisanne E. van Heijst, Xiaojuan Zhao, Ruben Y. Gabriëls, Wouter B. Nagengast
Background: Esophageal adenocarcinoma (EAC) is one of the main causes of cancer-related deaths worldwide and its incidence is rising. Barrett’s esophagus (BE) can develop low- and high-grade dysplasia which can progress to EAC overtime. The golden standard to detect dysplastic BE (DBE) or EAC is surveillance with high-definition white-light endoscopy (HD-WLE) and random biopsies according to the Seattle
-
Is PIPAC a Treatment Option in Upper and Lower Gastrointestinal Cancer with Peritoneal Metastasis? Visc. Med. (IF 1.9) Pub Date : 2022-03-21 Safak Guel-Klein, Miguel Enrique Alberto Vilchez, Wim Ceelen, Beate Rau, Andreas Brandl
Background: The survival prognosis of patients with peritoneal metastasis (PM) of gastrointestinal (GI) cancer is generally poor and treatment consists of, according to international guidelines, systemic chemotherapy. A multimodal treatment approach, including cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy, not only proved to be beneficial mainly in colorectal cancer
-
Today’s Mistakes and Tomorrow’s Wisdom in Endoscopic Treatment and Follow-Up of Barrett’s Esophagus Visc. Med. (IF 1.9) Pub Date : 2022-03-18 Maximilien Barret
Background: Endoscopic therapy has replaced esophagectomy for the management of early Barrett’s neoplasia, allowing for the curative treatment of intramucosal adenocarcinoma, dysplastic Barrett’s esophagus (BE), and the prevention of metachronous recurrences. Summary: Endoscopic therapy relies on the resection of any visible lesion, suspicious of harboring cancer, followed by the eradication of the
-
Tobacco Smoking and Gastrointestinal Cancer Risk Visc. Med. (IF 1.9) Pub Date : 2022-03-17 Hans Scherübl
Background: Smoking tobacco is the most preventable cause of gastrointestinal (GI) cancer disease in Germany. The more and the longer you smoke, the higher your risk of GI cancer. About 28% of 18–64 year-old Germans are current smokers; in addition, 11% of the population is regularly exposed to secondhand tobacco smoke. Summary: Tobacco use is causally associated with esophageal, gastric, pancreatic
-
Integration of Cytoreductive Surgery and Perioperative Chemotherapy into the Multidisciplinary Management of Intra-Abdominal Cancer Visc. Med. (IF 1.9) Pub Date : 2022-03-11 Paul H. Sugarbaker
Visc Med
-
Continuing Progress in the Interdisciplinary Management of Peritoneal Metastases Visc. Med. (IF 1.9) Pub Date : 2022-03-08 Beate Rau, Olivier Glehen, Paul H. Sugarbaker, M. Haroon A. Choudry, Yukata Yonemura, David L. Morris, Sebastian Stintzing, David P. Ryan
Visc Med
-
Transanal Endoscopic Microsurgical Submucosal Dissection: An Efficient Treatment Option for Giant Superficial Neoplastic Lesions of the Rectum Visc. Med. (IF 1.9) Pub Date : 2022-03-04 Konstantinos Kouladouros, Jörg Baral
Introduction: The resection of giant superficial neoplastic lesions of the rectum (#x3e;5 cm) is challenging even for experienced specialists. Endoscopic mucosal resection, endoscopic submucosal dissection (ESD), and transanal endoscopic microsurgery (TEM) have all been used for the treatment of such tumors. However, because of their individual disadvantages, the ideal technique for the treatment of
-
Surgical Management of Postoperative Grade C Pancreatic Fistula following Pancreatoduodenectomy Visc. Med. (IF 1.9) Pub Date : 2022-03-02 Orlando Jorge Martins Torres, José Maria Assunção Moraes-Junior, Eduardo de Souza Martins Fernandes, Thilo Hackert
____________________________________________________________________________________________ABSTRAC Background - The incidence of Grade C postoperative pancreatic fistula ranges from 2 to 11% depending on the type of pancreatic resection. This complication may frequently require early relaparotomy and the surgical approach remains technically challenging and is still associated with a high mortality
-
Today’s Mistakes and Tomorrow’s Wisdom… In Barrett’s Surveillance Visc. Med. (IF 1.9) Pub Date : 2022-03-01 Pauline A. Zellenrath, Carlijn A.M. Roumans, Manon C.W. Spaander
Background: Barrett’s esophagus (BE) is the only known precursor lesion of esophageal adenocarcinoma, a malignancy with increasing incidence and poor survival rates. To reduce mortality, regular endoscopic surveillance of BE patients is recommended to detect neoplasia in an (endoscopically) curable stage. In this review, we aim to provide an overview of current BE surveillance strategies, its pitfalls
-
Barrett’s Oesophagus: Today’s Mistake and Tomorrow’s Wisdom in Screening and Prevention Visc. Med. (IF 1.9) Pub Date : 2022-02-25 W. Keith Tan, Massimiliano di Pietro
Background: Oesophageal adenocarcinoma (OAC) is a lethal cancer with an overall 5-year survival of #x3c;20%. Given the presence of a pre-invasive disease stage, also known as Barrett’s oesophagus (BO), and the availability of minimally invasive treatments for BO-related neoplasia, it is thought that early detection is the best strategy to improve patient outcomes. Clinical guidelines recommend endoscopic
-
Indication of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer (Gastripec, Gastrichip) Visc. Med. (IF 1.9) Pub Date : 2022-02-23 Beate Rau, Linda Feldbrügge, Felix Gronau, Miguel Enrique Alberto Vilchez, Peter Thuss-Patience, Pierre Emmanuel Bonnot, Olivier Glehen
Background: Gastric cancer (GC) is associated with a poor prognosis mostly due to peritoneal metastasis, which will develop in time during the patient’s disease history. To prevent and treat peritoneal metastasis, different kinds of treatment regimens have been described. Summary: In this review, we addressed two main topics – prophylaxis and treatment of peritoneal metastasis in GC. Prevention should
-
Incomplete Cytoreduction of Colorectal Cancer Peritoneal Metastases: Survival Outcomes by a Cytoreduction Score Visc. Med. (IF 1.9) Pub Date : 2022-02-23
Background: The surgical management of peritoneal metastases from colorectal cancer has been a topic of controversial discussion for many decades. Peritonectomy and perioperative intraperitoneal chemotherapy added options for surgical treatment of this condition beyond palliative surgery. The most favorable outcomes are recorded when peritoneal metastases from colorectal cancer can be resected to no
-
-
An Extremely Rare Cause of an Obstructive Jaundice in Adults: Limited Langerhans Cell Histiocytosis of the Extrahepatic Bile Duct Visc. Med. (IF 1.9) Pub Date : 2022-02-07 Saeed Aldarwish, Clemens Schafmayer, Andreas Erbersdobler, Sebastian Hinz
Langerhans cell histiocytosis (LCH) is a rare group of idiopathic disorders (previously termed “histiocytosis X”) which is characterized by the presence of cells with characteristics similar to bone marrow-derived Langerhans cells which infiltrate various tissues and organs. Like Langerhans cells located in the skin, they express histiocytic markers such as S100, CD1a, and CD68 and contain Birbeck
-
Today’s Mistakes and Tomorrow’s Wisdom in Development and Use of Biomarkers for Barrett’s Esophagus Visc. Med. (IF 1.9) Pub Date : 2022-02-02 Nicola F. Frei, Matthew D. Stachler
Background: A histological diagnosis of dysplasia is our current best predictor of progression in Barrett’s esophagus (BE), the precursor of esophageal adenocarcinoma (EAC). Despite periodic endoscopic surveillance and assessment of dysplastic changes, we fail to identify the majority of those who progress before the development of EAC, whereas the majority of patients undergo endoscopy without showing
-
Management of Symptomatic Gallstone Disease during COVID-19 Lockdown in a High-Resource Setting: Is There a Need for Treatment Alterations? Visc. Med. (IF 1.9) Pub Date : 2022-01-27 Jens Strohaeker, Julia Sabrow, Can Yurttas, Alfred Königsrainer, Ruth Ladurner, Felix Hoenes
Introduction: Cholecystectomy (CCE) is the treatment of choice of symptomatic gallstones. Due to the SARS-CoV-2 pandemic, operating room (OR) capacities have been reduced. The goal of this study was to evaluate the duration of symptoms of patients presenting with gallstone disease during a lockdown, the surgical management, and the severity grade of their disease. Materials and Methods: A cohort study